Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (14.286%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.50
MAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

28 Jul 2015 13:41

RNS Number : 3252U
Marechale Capital PLC
28 July 2015
 

28 July 2015

 

Marechale Capital plc

("Marechale" or the "Company")

 

Consolidated Financial Statements for the year ended 31 March 2015.

 

Marechale is pleased to announce its final results for the year ended 31 March 2014

 

Chairman's Statement

We are pleased to report that Marechale completed the year strongly and, on the back of improving economic sentiment and more confidence in the equity markets, the Company's Gross Profit - revenue less commissions paid to 3rd parties - has increased by 39% from £517,600 to £719,000. Furthermore, as a result of our strategy of making investments in our client companies, we recorded 'Other Gains' (net) of £93,400 (2014: £152,400), resulting in a Profit before tax of £150,000 (2014: £79,400).

One part of our long-term strategic plan is to put the Company in a position to pay dividends and the Directors have decided to seek shareholder approval for a capital reorganisation that will be necessary before dividends can be paid. Shareholder approval will be sought at the 2015 AGM which is scheduled for the 17th September. Subject to receiving Court approval, it is planned subsequently to pay a dividend. A further announcement in this respect will be made in due course.

Another part of the long-term strategic plan is to motivate the Directors and staff by awarding them options which vest one third each year, over a three-year period, all tied to an uplift in the share price. At last year's AGM approval was obtained to award up to 10% of the issued share capital, of which 8%, were granted. It is the Board's intention to seek shareholder approval at this year's AGM for options to be granted on a further 10% of the issued share capital.

Marechale's core work is corporate finance advisory and capital fund raising for growth companies in two primary sectors in which the team have a long term track record; Leisure and Retail, and Renewable Energy.

Marechale helps management teams to finance or refinance in two key areas of activity; Growth Capital private equity transactions for more established businesses, and Development Capital, fundraising for smaller growth companies, the latter typically being Enterprise Investment Scheme (EIS) qualifying. As part of its success fee, the Company secures warrants or equity on most of its projects, so Marechale's shareholders have the opportunity to share in the potentially significant upside of the equity value in these businesses.

Equity investments and warrants are valued at 'fair value', typically at a price that reflects their last funding round, and the underlying unrealised movement in fair value is reflected (respectively) through the Revaluation Reserve and the Profit and Loss Account in accordance with IFRS9. Equity investments have increased by 40% to £151,700 and Warrants have increased by 66% to £128,250.

As a result of the above, and the Profit before tax, our Net assets have increased by 30% to £850,000.

During the year, Marechale has acted for a number of new and existing growth company clients, and has successfully completed a series of transactions, which are all detailed on the Company's website at: www.marechalecapital.com.

The Company's most significant initiative in the renewables sector is the development of large scale solar energy sites in the UK, through Marechale's associated company, Northfield UK Solar Limited (Northfield). Established in 2013, Northfield is developing a portfolio of solar sites. Marechale's stake in Northfield, at around 26% of the enlarged equity, is the Company's largest investment to date. As previously reported we are still awaiting the outcome of a planning appeal on the first site, on which a decision is due in the Autumn of 2015. Northfield's second large scale site is now in planning and we expect to hear a decision later this Summer. Whilst it is difficult to attribute values until planning permissions and grid connections for sites have been secured, there is significant potential uplift value for Marechale's shareholders; the valuation on the balance sheet represents the last funding round, and the Company's investment is being carried at £140,000, based on the Equity Method of valuation and including a provision to reflect the uncertainties of the planning process for its solar schemes and specifically a potential loss on appeal of the project mentioned above in proportion to Marechale's beneficial ownership % in Northfield. The environment for developing large scale solar schemes continues to be challenging, and whilst we are hopeful that value will be realised in due course, there are still significant risks involved.

Marechale has a growing reputation as one of the leading UK Advisors to the Leisure and Retail sector and, whilst it continues to see strong deal flow in this and its other core areas, it is always on the lookout for strong management teams with enterprising businesses in most sectors to support with growth and development capital. We remain committed to working with the management teams of quality companies to secure funding or refinancing capital from the Company's extensive list of private and institutional investors.

There is an appetite amongst our investor relationships to invest in high quality investment opportunities. The Directors believe that backing the right growth companies, whilst not without its risks, represents an interesting private equity investment class for investors looking to diversify their portfolios.

Marechale Capital is quoted on the AIM Market of the London Stock Exchange and continues to look at a number of potentially interesting acquisitions, investment and merger opportunities, particularly in fund management, and remains open to such approaches. However, none has been progressed to date. The Company is also looking to recruit staff to support its Corporate Finance and Sales activities.

 

Mark Warde-Norbury

Chairman

27 July 2015

 

 

 

For further information please contact:

 

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

 

Tel: +44 (0)20 7628 5582

Smith & Williamson Corporate Finance

Azhic Basirov / David Jones

 

Tel: +44 (0)20 7131 4000

 

 

Consolidated Income Statement

Year ended 31 March 2015

Year ended

Year ended

31-Mar

31-Mar

Notes

2015

2014

(£)

(£)

Continuing operations

Revenue

965,322

752,818

Cost of sales

2

(246,307)

(235,234)

Gross profit

719,015

517,584

Administrative expenses

(662,220)

(590,611)

Operating profit/ (loss)

56,795

(73,027)

Investment revenues

974

1,734

Other gains

72,458

31,361

Exceptional gain on dilution of interest in associate

166,140

141,125

Net loss in respect of associate

(31,191)

(21,786)

Provision for project loss in associate

(115,000)

-

Profit before tax

150,176

79,407

Taxation

-

-

Profit for the year on continuing operations

150,176

79,407

Profit per share

3

(Pence)

(Pence)

Basic

- Continuing operations

0.26

0.14

- Diluted

0.25

0.14

 

 

Consolidated Statement of Comprehensive Income

Year ended

Year ended

31-Mar

31-Mar

2015

2014

(£)

(£)

Profit for the year

150,176

79,407

Other comprehensive income

Revaluation of investments

38,246

12,254

38,246

12,254

Total recognised comprehensive income

(all attributable to owners of the parent)

188,422

91,661

 

 

 

Consolidated Balance Sheet

Year ended 31 March 2015

Year ended

Year ended

31-Mar

31-Mar

2015

2014

(£)

(£)

Non current assets

Investment in associate

139,794

119,845

Current assets

Available for sale investments

151,659

108,417

Trading investments

128,254

77,125

Trade and other receivables

491,108

221,003

Cash and cash equivalents

295,064

275,268

1,066,085

681,813

Total assets

1,205,879

801,658

Current liabilities

Trade and other payables

(356,043)

(149,319)

Total current liabilities

(356,043)

(149,319)

Net assets

849,836

652,339

Equity

Capital and reserves attributable to equity shareholders

Share capital

2,474,308

2,474,308

Share premium account

1,247,379

1,247,379

Revaluation reserve

90,135

51,889

Reserve for own shares

(50,254)

(50,254)

Retained losses

(2,920,807)

(3,070,983)

Reserve for share based payments

9,075

-

849,836

652,339

 

 

Statement of Changes in Equity

Year ended 31 March 2015

Share capital

Share premium

Revaluation reserve

Reserve for own shares

Retained earnings

Consolidated 

(£)

(£)

(£)

(£)

(£)

Balance at 31 March 2013

2,474,308

1,247,379

39,635

(50,254)

(3,150,390)

Issue of ordinary share capital

-

-

-

-

-

Release of reserve for lapsed options

-

-

-

-

-

Transactions with owners

-

-

-

-

-

Total comprehensive income

Profit for the financial year

-

-

-

-

79,407

Revaluation during the financial year

-

-

12,254

-

-

Total comprehensive income

-

-

12,254

-

79,407

Balance at 31 March 2014

2,474,308

1,247,379

51,889

(50,254)

(3,070,983)

Issue of ordinary share capital

-

-

-

-

-

Reserve for share based payments

-

-

-

-

9,075

Transactions with owners

0

0

-

-

9,075

Total comprehensive income

Profit for the financial year

-

-

-

-

150,176

Revaluation during the financial year

-

-

38,246

-

-

Total comprehensive income

-

-

38,246

-

150,176

Balance at 31 March 2015

2,474,308

1,247,379

90,135

(50,254)

(2,911,732)

Company 

Balance at 31 March 2013

2,474,308

1,247,379

39,635

(50,254)

(3,150,390)

Issue of ordinary share capital

-

-

-

-

-

Release of reserve for lapsed options

-

-

-

-

-

Transactions with owners

-

-

-

-

-

Total comprehensive income

Loss for the financial year

-

-

-

-

(39,930)

Revaluation during the financial year

-

-

12,254

-

-

Total comprehensive income

-

-

12,254

-

(39,930)

Balance at 31st March 2014

2,474,308

1,247,379

51,889

(50,254)

(3,190,320)

Issue of ordinary share capital

-

-

-

-

-

Reserve for share based payments

-

-

-

-

9,075

Transactions with owners

-

-

-

-

9,075

Total comprehensive income

Profit for the financial year

-

-

-

-

130,227

Revaluation during the financial year

-

-

38,246

-

-

Total comprehensive income

-

-

38,246

-

130,227

Balance at 31 March 2015

2,474,308

1,247,379

90,135

(50,254)

(3,051,018)

 

 

Movements of the Revaluation reserve consist of:

2015

2014

Unrealised gains

38,246

12,254

38,246

12,254

Reserves for own shares consists of:

Reserve for employee share ownership plan ('ESOP')

(50,254)

(50,254)

(50,254)

(50,254)

The Reserve for ESOP comprises 232,603 shares in the Group held in an ESOP Trust. As at 31 March 2015 (2014: nil), all the shares had been unconditionally granted to the Group's Associates which had an aggregate market value of £3,489 (2014: £4,652). 

 

 

Consolidated Cash Flow Statement

Year ended 31 March 2015

 

Year ended

Year ended

31-Mar

31-Mar

2015

2014

(£)

(£)

Net cash from operating activities

Continuing operations: Operating profit/ (loss)

56,795

(73,027)

Provision for share based payments

9,075

-

Operating cash flows before movements in working capital

65,870

(73,027)

Movement in working capital

(Increase) in receivables

(270,105)

(28,438)

Increase in payables

206,726

63,275

Tax paid

-

-

(63,379)

34,837

Operating cash flow

2,491

(38,190)

Investment activities

Interest receivable

974

1,734

Proceeds on disposal of trading investments

17,705

44,807

Proceeds on disposal of available for sale investments

3,626

5,205

Expenditure on available for sale investments

(5,000)

(506)

Cash flow from investing activities

17,305

51,240

Financing

Issue of share capital

-

-

Cash flow from financing activities

-

-

Net increase in cash and cash equivalents

19,796

13,050

Cash and cash equivalents at start of the financial year

275,268

262,218

Cash and cash equivalents at end of the financial year

295,064

275,268

Increase in cash and cash equivalents

19,796

13,050

 

 

Notes to the financial statements

Year ended 31 March 2015

 

1. Basis of preparation

These financial statements have been prepared in accordance with International Financial Reporting Standards ('IFRS') as adopted by the European Union and the International Financial Reporting Interpretations Committee ('IFRIC') interpretations in accordance with the Companies Act 2006. The financial statements have been prepared on the historical cost basis as modified by the valuation of certain financial instruments.

 

2. Business and geographical segments

The directors consider that there is only one activity undertaken by the Group, that of corporate finance advisory. All of this activity was undertaken in the United Kingdom.

2015

2014

(£)

(£)

Broking commissions and fees earned from corporate finance

965,322

752,818

 

3. Earnings per share

Earnings

Earnings

(£)

(£)

Based on a profit of

150,176

79,407

No. shares

No. shares

Weighted average number of Ordinary Shares in issue

57,681,151

57,681,151

for the purpose of basic earnings per share

Weighted average number of Ordinary Shares in issue

59,988,397

57,681,151

for the purpose of diluted earnings per share - see also Note 5

 

4. Other Matters

The financial information for the year ended 31 March 2015 set out in this announcement does not constitute statutory financial statement, as defined in section 434 of the Companies Act 2006, but is based on the statutory financial statements for the year then ended. Those financial statements, upon which the auditors have issued an unqualified opinion, will be delivered to the Registrar of Companies.

 

Copies of the Company's full audited Annual Report and Financial Statements for the year ended 31 March 2015 will be sent to shareholders in due course and will be available on the Company's website: www.marechalecapital.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR RPMTTMBJTBLA
Date   Source Headline
5th Dec 20237:00 amPRNHalf-year Report
22nd Nov 20231:00 pmPRNDirectorate Change
13th Oct 20233:51 pmPRNResult of AGM
19th Sep 20233:40 pmPRNNotice of AGM and Posting of Accounts
22nd Aug 20237:00 amPRNFinancial Statements for the Year Ended 30 April 2023
3rd Aug 202312:00 pmPRNHolding(s) in Company
28th Jun 20237:00 amPRNSubscription and Issue of Equity
2nd Mar 20227:00 amPRNPlacing, Subscription and Issue of Equity
1st Dec 20217:00 amPRNHalf-year Report
14th Oct 20213:28 pmRNSResult of AGM
11th Oct 20213:08 pmPRNHolding(s) in Company
8th Oct 20213:29 pmPRNHolding(s) in Company
5th Oct 20217:00 amPRNSubscription and Issue of Equity
22nd Sep 20212:57 pmPRNNotice of AGM
8th Sep 202111:54 amPRNHolding(s) in Company
7th Sep 20212:11 pmPRNDirector/PDMR Shareholding
23rd Aug 20217:00 amRNSFinal Results
12th Mar 20219:32 amPRNHolding(s) in Company
5th Mar 20211:29 pmPRNHolding(s) in Company
5th Mar 20218:50 amPRNHolding(s) in Company
4th Mar 20213:24 pmPRNTrading Update
4th Mar 20219:19 amPRNHolding(s) in Company
23rd Feb 20215:00 pmPRNHolding(s) in Company
23rd Feb 20217:00 amPRNDirector/PDMR Shareholding
10th Feb 20212:27 pmPRNHolding(s) in Company
10th Feb 20217:00 amPRNHolding(s) in Company
4th Feb 20219:15 amPRNExercise of Options and Issue of Equity
3rd Feb 20217:00 amPRNStatement re Share Price Movement
2nd Feb 20216:20 pmPRNHolding(s) in Company
26th Jan 202111:47 amPRNPlacing, Subscription and Issue of Equity
11th Dec 202012:47 pmPRNGrant of Options to Directors
24th Nov 20207:00 amPRNHalf-year Report
26th Oct 20201:16 pmPRNResult of AGM
2nd Oct 20207:00 amRNSChange of Adviser
28th Sep 20201:20 pmRNSPosting of Annual Report and Notice of AGM
25th Aug 202010:39 amRNSHolding(s) in Company
24th Aug 20207:00 amRNSFinal Results
10th Aug 202010:03 amRNSHolding(s) in Company
7th Aug 20201:05 pmRNSHolding(s) in Company
6th Aug 202010:09 amRNSHolding(s) in Company
5th Aug 202011:35 amRNSHolding(s) in Company
4th Aug 20201:03 pmRNSHolding(s) in Company
30th Jul 20204:40 pmRNSSecond Price Monitoring Extn
30th Jul 20204:35 pmRNSPrice Monitoring Extension
17th Jan 20203:31 pmRNSHolding(s) in Company
12th Dec 20193:08 pmRNSHalf-year Report
24th Sep 201912:16 pmRNSHolding(s) in Company
23rd Sep 20193:38 pmRNSResult of AGM
2nd Sep 20192:46 pmRNSPosting of Annual Report and Notice of AGM
29th Aug 20193:48 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.